Simon N - Search Results

1

[How may practitioners interpret the results of clinical trials?].

Azorin JM, Adida M, Blin O, Simon N, Fakra E, Cermolacce M, Bottai T, Pringuey D, Micoulaud-Franchi JA, Belzeaux R, Kaladjian A. Azorin JM, et al. Among authors: simon n. Encephale. 2016 Dec;42(6S):S26-S29. doi: 10.1016/S0013-7006(17)30050-7. Encephale. 2016. PMID: 28236989 French.

2

Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteers.

Blin O, Simon N, Jouve E, Habib M, Gayraud D, Durand A, Bruguerolle B, Pisano P. Blin O, et al. Among authors: simon n. Clin Neuropharmacol. 2001 Mar-Apr;24(2):71-81. doi: 10.1097/00002826-200103000-00002. Clin Neuropharmacol. 2001. PMID: 11307041 Clinical Trial.

3

End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: a pharmacokinetic/pharmacodynamic, randomized, double-blind study.

Simon N, Micallef J, Reynier JC, Lesourd M, Witjas T, Alicherif A, Azulay JP, Blin O. Simon N, et al. Mov Disord. 2005 Jul;20(7):803-9. doi: 10.1002/mds.20400. Mov Disord. 2005. PMID: 15726579 Clinical Trial.

4

[Rational estimation of drug dosage through pharmacometric modeling: The case of a long-acting depot antipsychotic].

Simon N, Azorin JM. Simon N, et al. Encephale. 2015 Apr;41(2):159-67. doi: 10.1016/j.encep.2015.02.001. Epub 2015 Mar 9. Encephale. 2015. PMID: 25765186 French.

5

Pharmacological treatment of schizophrenia with comorbid substance use disorder.

Azorin JM, Simon N, Adida M, Belzeaux R. Azorin JM, et al. Among authors: simon n. Expert Opin Pharmacother. 2016;17(2):231-53. doi: 10.1517/14656566.2016.1114101. Epub 2015 Dec 4. Expert Opin Pharmacother. 2016. PMID: 26635059 Review.

6

[Negative symptoms in schizophrenia and substance-related disorders].

Simon N, Belzeaux R, Adida M, Azorin JM. Simon N, et al. Encephale. 2015 Dec;41(6 Suppl 1):6S27-31. doi: 10.1016/S0013-7006(16)30007-0. Encephale. 2015. PMID: 26776388 Review. French.

7

[Negative symptoms in schizophrenia: psychotherapeutic approaches].

Azorin JM, Adida M, Belzeaux R, Pringuey D, Micoulaud Franchi JA, Simon N, Cermolacce M, Kaladjian A, Fakra E. Azorin JM, et al. Among authors: simon n. Encephale. 2015 Dec;41(6 Suppl 1):6S57-60. doi: 10.1016/S0013-7006(16)30012-4. Encephale. 2015. PMID: 26776394 Review. French.

8

[What role for paraclinical investigations within clinical trials conducted in psychiatric patients?].

Kaladjian A, Adida M, Simon N, Belzeaux R, Blin O, Fakra E, Azorin JM. Kaladjian A, et al. Among authors: simon n. Encephale. 2016 Dec;42(6S):S47-S50. doi: 10.1016/S0013-7006(17)30054-4. Encephale. 2016. PMID: 28236993 French.

9

[Modeling for clinical trial in psychiatry: rationale, benefits and limitations].

Simon N, Azorin JM, Belzeaux R, Adida M, Kaladjian A. Simon N, et al. Encephale. 2016 Dec;42(6S):S7-S11. doi: 10.1016/S0013-7006(17)30047-7. Encephale. 2016. PMID: 28236996 French.

10

Alcohol use and bipolar disorders: Risk factors associated with their co-occurrence and sequence of onsets.

Azorin JM, Perret LC, Fakra E, Tassy S, Simon N, Adida M, Belzeaux R. Azorin JM, et al. Among authors: simon n. Drug Alcohol Depend. 2017 Oct 1;179:205-212. doi: 10.1016/j.drugalcdep.2017.07.005. Epub 2017 Aug 3. Drug Alcohol Depend. 2017. PMID: 28802190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,538 results

Search Page

Filters